Healthcare IT teams are facing a ticking clock as Citrix patches critical vulnerabilities (CVE-2026-3055 and CVE-2026-4368) affecting NetScaler ADC and Gateway, which serve as the primary gateway for ...

Citrix monitoring is essential to keep applications responsive, secure, and reliable across complex hybrid environments. Leveraging real-time metrics, targeted diagnostics, and proactive alerts allows ...

The U.S. cybersecurity agency ordered Federal Civilian Executive Branch agencies to implement fixes for the issue by end of day Friday. A critical-severity vulnerability affecting two Citrix NetScaler ...

F5, Inc. is rated a Hold, and delivered a strong Q2'26, with 11% revenue growth and robust product momentum. Read more on ...

The African Democratic Congress (ADC) has begun free online membership registration across Nigeria, expanding its nationwide drive that started with a physical registration and revalidation exercise ...

The Citrix-Tibco deal passed a shareholder vote in April. Virtualization and cloud products vendor Citrix and enterprise applications vendor Tibco Software have completed their merger, valued at $16.5 ...

The African Democratic Congress, ADC, on Tuesday successfully concluded its national convention in Abuja, with delegates overwhelmingly voting to amend the party’s constitution. DAILY POST reports ...

Following its disputed national convention, held despite the Independent National Electoral Commission’s refusal to recognise any faction of the party, the African Democratic Congress still faces a ...

The African Democratic Congress has confirmed that over 3,000 delegates are expected to attend its national convention scheduled for April 14 in Abuja, as the party moves ahead with preparations ...

Eli Lilly's acquisition spree shows no sign of stalling, although the Big Pharma is keeping the terms of its latest buy pretty vague. This time, Lilly has returned to antibody-drug conjugates (ADCs), ...

First-in-human, multicenter phase Ⅰ study of TGRX-326 in patients with advanced ALK-positive non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...

BAT8008, a TROP-2 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1 study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...